These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3138384)

  • 1. In vivo voltammetric study of 6-hydroxydopamine-induced neuronal degradation.
    Nakazato T; Akiyama A
    J Neurochem; 1988 Oct; 51(4):1007-13. PubMed ID: 3138384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exogenous L-dopa on behavior in the rat: an in vivo voltammetric study.
    Nakazato T; Akiyama A
    Brain Res; 1989 Jun; 490(2):332-8. PubMed ID: 2765866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis.
    Zetterström T; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1986 Jun; 376(1):1-7. PubMed ID: 3087581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion.
    Zigmond MJ; Stricker EM
    Experientia; 1980 Apr; 36(4):436-8. PubMed ID: 7379917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-dopa induced increases in brain uric acid in an animal model of Parkinson's disease: a relationship to behavioral activation.
    Pinheiro-Carrera M; Tomaz C; Huston JP; Dai H; Carey RJ
    Life Sci; 1994; 55(13):991-7. PubMed ID: 8084215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of haloperidol administration on in vivo extracellular dopamine in striatum and prefrontal cortex after partial dopamine lesions.
    Bean AJ; Roth RH
    Brain Res; 1991 May; 549(1):155-8. PubMed ID: 1909923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
    Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
    Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.
    Miller DW; Abercrombie ED
    J Neurochem; 1999 Apr; 72(4):1516-22. PubMed ID: 10098856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental stress increases extracellular dopamine in striatum of 6-hydroxydopamine-treated rats: in vivo microdialysis studies.
    Keefe KA; Stricker EM; Zigmond MJ; Abercrombie ED
    Brain Res; 1990 Sep; 527(2):350-3. PubMed ID: 2123730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of L-dopa on in vitro dopamine release from striatum.
    Snyder GL; Zigmond MJ
    Brain Res; 1990 Feb; 508(2):181-7. PubMed ID: 2106362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
    Javoy F; Sotelo C; Herbet A; Agid Y
    Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
    Sivam SP
    Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum.
    Ichitani Y; Okamura H; Matsumoto Y; Nagatsu I; Ibata Y
    Brain Res; 1991 May; 549(2):350-3. PubMed ID: 1679369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficits in locomotor behaviour and motor performance after central 6-hydroxydopamine or peripheral L-DOPA.
    Willis GL; Smith GC; McGrath BP
    Brain Res; 1983 May; 266(2):279-86. PubMed ID: 6409350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.